Inflammation and immunoreaction markers were correlated with the survival of patients in many tumors. However, there were no reports investigating the relationships between preoperative hematological markers and the prognosis of medulloblastoma (MB) patients based on the molecular subgroups (WNT, SHH, Group 3, and Group 4). A total 144 MB patients were enrolled in the study. The differences of preoperative hematological markers among molecular subgroups of MB were compared by One-way ANOVA method. Kaplan-Meier method was used to calculate the curves of progression free survival (PFS) and overall survival (OS). The comparison of survival rates in different groups were conducted by the Log-rank test. Multivariate analysis was used to evaluate independent prognostic factors. Increased preoperative NLR (neutrophil-to-lymphocyte ratio, PFS, P = 0.004, OS, P < 0.001) and PLR (platelet-to-lymphocyte ratio, PFS, P = 0.028, OS, P = 0.003) predicted poor prognosis in patients with MB, while preoperative MLR (monocyte-to-lymphocyte ratio), MPV (mean platelet volume), PDW (platelet distribution width), and AGR (albumin-to-globulin ratio) were revealed no predictive value on the prognosis of patients with MB. Furthermore, high preoperative NLR and PLR predicted unfavorable prognosis in childhood MB patients. However, preoperative NLR and PLR were not associated with the prognosis in adult MB patients. Multivariate analysis demonstrated preoperative NLR (PFS, P = 0.029, OS, P = 0.005) and PLR (PFS, P = 0.023, OS, P = 0.005) were the independent prognostic factors in MB patients. Emphatically, the levels of preoperative NLR and PLR in Group 3 MB were significantly higher than those in WNT MB. High preoperative NLR was associated with unfavorable OS in Group 3 (P = 0.032) and Group 4 (P = 0.027) tumors. Similarly, increased preoperative PLR predicted poor PFS (P = 0.012) and OS (P = 0.009) in Group 4 tumors. Preoperative NLR and PLR were the potential prognostic markers for MB patients. Preoperative NLR and PLR were significantly associated with the survival of Group 3 and Group 4 tumors.
www.nature.com/scientificreports www.nature.com/scientificreports/ carcinoma, and glioblastoma, etc. [2] [3] [4] [5] . Specifically, increased preoperative neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) were reported poor prognosis in patients with solid cancers [6] [7] [8] . Reduced preoperative mean platelet volume (MPV) was discovered in patients with renal cell carcinoma compared to the patients with benign renal tumor 9 . Moreover, preoperative platelet distribution width (PDW) was demonstrated as an independent risk factor for the prognosis with gastric cancer 10 . However, to our knowledge, no studies have investigated the prognostic significance of preoperative hematological markers in MB patients.
The determination of molecular subgroups was one of the most important advancements in the realm of MB investigation. Mounting evidences demonstrated that MB is a heterogenous disease and composed of different molecular subgroups: sonic hedgehog (SHH), wingless (WNT), Group 3, and Group 4. These subgroups are significantly different in transcriptional profiles, genetic abnormalities, clinical characteristics, and prognosis 1, 11 . Recently, the four MB molecular subgroups have been included in the newest 2016 World Health Organization classification of tumors of the central nervous system 12 . Nevertheless, whether the prognostic value of hematological markers differ in molecular subgroups of MB remains unexplored.
The purpose of the present study was to investigate the prognostic significance of the preoperative hematological markers (NLR, PLR, MLR, MPV, PDW, and albumin-to-globulin ratio (AGR)) combined with molecular subgroups (WNT, SHH, Group 3, and Group 4) on the survival of patients with MB.
Results clinicopathologic characteristics. 144 MB patients had complete preoperative hematological markers
without preoperative infection diseases and systemic comorbidities were enrolled in the study ( Supplementary  Fig. 1 Table 1) .
Preoperative NLR and PLR were the independent prognostic markers in MB patients. We used the X-tile 3.6.1 software to calculate the cutoff values, and the cutoff values of the preoperative NLR, PLR, MLR, MPV, PDW and AGR for progression free survival (PFS) and overall survival (OS) were listed in Tables 1 and  2 . Following 116 MB patients were analysed by univariate analysis (Supplementary Fig. 1 ). High preoperative NLR (P = 0.004, P < 0.001, Tables 1 and 2 , Figs 2A and 3A) predicted unfavorable PFS and OS in MB patients. Similarly, high preoperative PLR (P = 0.028, P = 0.003, Tables 1 and 2 , Figs 2B and 3B) was correlated with unfavorable PFS and OS in patients with MB. Subtotal resection (P < 0.001, P < 0.001, Tables 1 and 2 ) and no RT (P = 0.003, P < 0.001, Tables 1 and 2 ) were significantly associated with unfavorable PFS and OS with patients in MB. The tumors located in midline predicted poor PFS (P = 0.048, Table 1 ) in patients with MB.
In multivariate analysis, we analyzed preoperative NLR and PLR separately because they were strongly correlated and interfered with each other 13 . The results revealed that preoperative NLR (PFS, P = 0.029, OS, P = 0.005, Table 3 ), preoperative PLR (OS, P = 0.012, Table 4), the extent of resection (PFS, P = 0.012, OS, P = 0.011, Table 3 , PFS, P = 0.014, OS, P = 0.014, Table 4 ) and RT (PFS, P = 0.009, OS, P = 0.001, Table 3 , PFS, P = 0.010, OS, P = 0.001, Table 4) were the independent prognostic factors for the MB patients. When the factor of molecular subgroups was added in multivariate analyses, preoperative NLR lost independent significance in the multivariate analysis for PFS (P = 0.090, Supplementary Table 2). After adjusting for molecular subgroups, preoperative NLR and PLR were still the independent prognostic factors (OS, P = 0.013, Supplementary Table 1 . Univariate analysis of prognostic parameters for PFS in medulloblastoma patients (n = 116). PreKPS: preoperative karnofsky performance status scale. RT: postoperative primary radiotherapy. CHT: postoperative primary chemotherapy. NLR: neutrophil-to-lymphocyte ratio. PLR: platelet-to-lymphocyte ratio. MLR: monocyte-to-lymphocyte ratio. MPV: mean platelet volume. PDW: platelet distribution width. AGR: preoperative albumin-to-globulin ratio.
The exact mechanism about the role of preoperative NLR in the prognosis of tumors need to be fully elucidated. Elevated NLR means more neutrophils, fewer lymphocytes, or both. On the one hand, elevated neutrophils could promote tumor invasion and metastasis by releasing many reactive oxygen species 14 and cytokines including interleukin-1 (IL-1), tumor necrosis factor (TNF) and vascular endothelial growth factor (VEGF), etc. 15, 16 . The reactive oxygen species could induce the DNA damage and genetic instability, and the cytokines promoted to tumor angiogenesis, proliferation and metastasis 17, 18 . On the other hand, the tumor infiltrating lymphocytes (TILs) which were differentiated from the T-lymphocytes were considered as systemic and local indicators of anti-tumor reaction. Reduced of TILs were revealed associated with poor prognosis in tumors 19 . A recent study revealed that a decreased infiltrating CD8+ T lymphocyte predicted poor prognosis in patients with MB 20 . Therefore, elevated NLR may indicate the poor prognosis of the patients with MB. In addition, we also found that preoperative NLR in Group 3 MB were significantly higher than those in WNT MB. This finding was in accordance with that the prognosis of WNT MB were significantly better than those in Group 3 MB. In addition, high www.nature.com/scientificreports www.nature.com/scientificreports/ preoperative NLR was revealed associated with short OS in Group 3 and Group 4 MB. These findings indicated the differential prognostic significances of preoperative NLR in the four molecular subgroups of MB.
The preoperative PLR was also revealed to play an important role in predicting the prognosis in patients with MB. It had been revealed the platelet receptors such as GP1b/IX/V, P-selectin and alphaIIb-beta3 integrin www.nature.com/scientificreports www.nature.com/scientificreports/ were associated with various tumor progression and metastasis. Additionally, the platelets could release over 30 important angiogenesis regulating proteins in which VEGF was the most important 21 . The levels of VEGF mRNA in Group 3 subgroup (which prognosis is the worst) were significantly higher than those with the other subgroups in patients with MB 22 . Furthermore, the platelets activation and platelets related-protein contributed to the inflammatory response, which could lead to neutrophilia, leukocytosis, thrombocytosis and lymphocytopenia 23, 24 . And the platelets protein was reported to enhance the tumor growth and metastasis 21 . Xia, et al. and Yun, et al. reported that the pretreatment PLR was an independent risk factor for OS in patients with osteosarcoma and renal cell carcinoma 4, 24 . In our study, high preoperative PLR was associated with poor PFS and OS in MB patients, particularly high preoperative PLR predicted poor PFS and OS in Group 4 MB.
There exist controversies in the prognostic roles of preoperative MLR, MPV, PDW and AGR in cancers. For example, high preoperative MLR was associated with poor survival in colorectal cancer 3 and esophageal cancer 2 . However, a recent study revealed that preoperative MLR exhibited no prognostic value in glioblastoma 13 . Similarly, recent studies demonstrated that decreased preoperative MPV had a relationship with unfavorable www.nature.com/scientificreports www.nature.com/scientificreports/ prognosis of the renal cell carcinoma 9 and gliomas 25 . On the contrary, a study revealed that high preoperative MPV had poor prognosis in patients with lung cancer 26 . Additionally, Zhang, et al. illustrated that decreased preoperative PDW had an unfavorable prognosis in stomach cancer 10 . However, other researches revealed that high preoperative PDW had unfavorable prognosis in laryngeal cancer 27 and melanoma 28 . Previous studies showed that low preoperative AGR had unfavorable OS in breast cancer and colorectal cancer 29, 30 . Our study revealed that preoperative MLR, MPV, PDW and AGR had no prognostic value in MB patients, and the levels of preoperative MLR, MPV, PDW, and AGR among WNT, SHH, Group 3, and Group 4 MB had no significant differences.
Previous study 31 reported that gross total tumor resection predicted better PFS and OS in MB patients. In our study, the gross total tumor resection correlated with more favorable PFS and OS in our series in the univariate analysis. Moreover, the extent of resection was the independent prognostic factor in MB patients in the multivariate analysis. Therefore, our results corroborated that the extent of resection is one of the most significant predictors of PFS and OS in MB patients.
In the multivariate analyses without molecular subgroups, preoperative NLR and PLR were the independent prognostic factors for PFS and OS in MB patients. When molecular subgroups were added in multivariate analyses, preoperative NLR lost independent significance in the multivariate analysis for PFS. After adding molecular subgroup in the multivariate analyses, preoperative NLR and PLR were still the independent prognostic factors for OS. The OS could be influenced by the differences in the protocols of salvage treatment after tumor recurrence and this might confuse the prognostic significance of hematological markers in MB. Our results indicate preoperative NLR may be influenced by molecular subgroups in PFS. Future cohorts with relatively homogeneous salvage adjuvant therapies and larger sample size are needed to further clarify this question.
In our opinion, we think a One-way ANOVA model with pairwise comparison is appropriate for comparing across multiple groups here. Whereas a One-way ANOVA model assesses whether a significant difference exists among all the groups, pairwise comparisons can be used to determine which groups' differences are statistically significant. Eckel-Passow, J. E. et al. 32 previously used pairwise comparisons in One-way ANOVA statistics in their paper.
Admittedly, some limitations existed in present study. Firstly, the incidence of MB is low. Some studies reported that the estimated incidence of MB in children was about 0.5/100,000 33, 34 . Moreover, MB represented a rare tumor in adults and comprised less than 1% of adult primary brain neoplasms 35 . Compared to previous study 36 , the current cohort of 116 MB patients with complete survival data and molecular subgroup information may not be sufficient to draw final conclusions, especially when the cohort was divided into four molecular subgroups. Therefore, these findings revealed by the current study should be interpreted with caution. Secondly, our research was based on a single-center retrospective study and the findings should be corroborated by multi-centre prospective studies. Thirdly, we revealed preoperative NLR and PLR were correlated with the survival of MB patients based on molecular subgroups, but the exact mechanism between the levels of preoperative NLR, PLR and molecular subgroups need further investigation. Last not the least, according to previous studies 37, 38 , patients with disseminated MB are classified according to Chang's operative staging system. Due to the lack of Chang classification data, we could not investigate whether high preoperative NLR/PLR predict patients with higher probability of experiencing metastasis of MB in the current study.
In conclusion, we firstly demonstrated high preoperative NLR and PLR were significantly correlated with poor survivals of patients with MB. Moreover, the levels of preoperative NLR and PLR in Group 3 MB were significantly higher than those in WNT MB. High preoperative NLR and PLR predict unfavorable survival in Group 3 and Group 4 MB. These findings indicate preoperative NLR and PLR can be used as prognostic predictors for Group 3 and Group 4 MB patients. www.nature.com/scientificreports www.nature.com/scientificreports/ 
Statistical methods.
Statistical analyses were performed using SPSS 21.0 (IBM Crop, Armonk, NY, USA), Graph-Pad Prism 5.0 (Graph-Pad Inc, La Jolla, USA) and X-tile 3.6.1 (http://medicine.yale.edu/lab/rimm/ research/software.aspx). The differences of preoperative hematological markers between WNT, SHH, Group 3, and Group 4 were compared by One-way ANOVA. Kaplan-Meier method was used to calculate survival curves. The comparison of survival rates in different groups were conducted by the Log-rank test (univariate analysis). Cox proportional hazards regression model was used to evaluate independent prognostic factors (multivariate analysis). Values of P < 0.05 were considered as statistically significant.
Our research was approved by the Human Scientific Ethics Committee of the First Affiliated Hospital of Zhengzhou University. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. An informed consent was obtained from all individual participants included in the study.
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